2022
DOI: 10.3390/pharmaceutics14061235
|View full text |Cite
|
Sign up to set email alerts
|

Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies

Abstract: Biomedical research devotes a huge effort to the development of efficient non-viral nanovectors (NV) to improve the effectiveness of standard therapies. NVs should be stable, sustainable and biocompatible and enable controlled and targeted delivery of drugs. With the aim to foster the advancements of such devices, this review reports some recent results applicable to treat two types of pathologies, cancer and microbial infections, aiming to provide guidance in the overall design of personalized nanomedicines a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
2

Relationship

5
5

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 143 publications
0
13
0
Order By: Relevance
“…Recently, another challenging strategy used to develop antimicrobial therapeutics is the use of lipopeptides or carbohydrates to develop nanosystems that are decorated on their surface with AMPs [ 107 ].…”
Section: Applications Of Glycosylation and Lipidation To Improve Acti...mentioning
confidence: 99%
“…Recently, another challenging strategy used to develop antimicrobial therapeutics is the use of lipopeptides or carbohydrates to develop nanosystems that are decorated on their surface with AMPs [ 107 ].…”
Section: Applications Of Glycosylation and Lipidation To Improve Acti...mentioning
confidence: 99%
“…The concept of NFs for drug delivery is explored in our laboratory using peptide amphiphile molecules, which can self-assemble into cylindrical nanofibers easily decorated on their surface with the desired moieties for achieving the desired bio-application (for a comprehensive review on the use and advantages of peptides for anticancer therapies see ref [ 35 ]). Here, it was possible to develop NFs with Doxo and gH625, both loaded from 1 to 15 µM per 100 µM of total peptide concentration.…”
Section: Discussionmentioning
confidence: 99%
“…20 This strategy is known as the Trojan horse approach. 21 Similarly, antimicrobial peptides (AMPs), which are widely studied and considered a promising alternative to traditional antibiotics for their mode of action, 22–28 may be linked to siderophore–iron chelators to reduce the iron availability for bacterial growth and enhance their efficacy (Fig. 1).…”
Section: Introductionmentioning
confidence: 99%